Literature DB >> 1364839

Comparison of the effects of several potassium-channel openers on rat bladder and rat portal vein in vitro.

G Edwards1, M Henshaw, M Miller, A H Weston.   

Abstract

1. The ability of several K-channel openers to inhibit KCl-induced contractions of rat bladder detrusor and spontaneous mechanical activity in rat portal vein was examined. 2. Lemakalim, pinacidil, Ro 31-6930, RP 49356, P1060 and S 0121 dose-dependently relaxed rat detrusor, precontracted with 20 mM KCl. With the exception of pinacidil, concentrations of these agents below 30 microM did not inhibit 80 mM KCl-included contractions. Pinacidil (10 microM) produced a small, but significant (P < 0.05) relaxation of 80 mM KCl-induced mechanical activity. Minoxidil sulphate and BRL 38226 produced some relaxation of 20 mM but not 80 mM KCl-induced contractions. 3. Glibenclamide (0.3-3 microM) antagonized the relaxant effects of lemakalim, pinacidil, Ro 31-6930, RP 49356, P1060 and S 0121 in a competitive manner (pA2 values 6.3-6.6). The effects of minoxidil sulphate and BRL 38226 were fully antagonized by 3 microM glibenclamide. 4. Lemakalim, pinacidil, S 0121, BRL 38226 and minoxidil sulphate were each approximately 8 times more potent as inhibitors of the spontaneous contractions of rat portal vein than KCl-induced contractions of the rat detrusor. Minoxidil sulphate was approximately 30 times more potent in the rat portal vein than in the bladder. This may indicate that either minoxidil sulphate is acting at different recognition sites in these two tissues, or that this compound has an additional mechanism of action in the portal vein. 5. With the exception of minoxidil sulphate, all the compounds tested stimulated 86Rb efflux and 42K efflux from preloaded rat detrusor strips. The stimulated 86Rb efflux was qualitatively but not quantitatively similar to the stimulated 42K efflux. Minoxidil sulphate stimulated 42K efflux from rat portal vein but not from rat bladder. 6. It is concluded that all the compounds tested cause relaxation of rat detrusor predominantly by Kchannel opening. Selectivity for bladder rather than vascular smooth muscle was not shown by any compound.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1364839      PMCID: PMC1917957          DOI: 10.1111/j.1476-5381.1991.tb12233.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  27 in total

1.  Preclinical pharmacology of Ro 31-6930, a new potassium channel opener.

Authors:  P M Paciorek; D T Burden; Y M Burke; I S Cowlrick; R S Perkins; J C Taylor; J F Waterfall
Journal:  J Cardiovasc Pharmacol       Date:  1990-02       Impact factor: 3.105

2.  The effects of BRL 34915 and nicorandil on electrical and mechanical activity and on 86Rb efflux in rat blood vessels.

Authors:  S W Weir; A H Weston
Journal:  Br J Pharmacol       Date:  1986-05       Impact factor: 8.739

Review 3.  Pinacidil. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in the treatment of hypertension.

Authors:  H A Friedel; R N Brogden
Journal:  Drugs       Date:  1990-06       Impact factor: 9.546

4.  BRL 34915, a novel antihypertensive agent: comparison of effects on blood pressure and other haemodynamic parameters with those of nifedipine in animal models.

Authors:  R E Buckingham; J C Clapham; T C Hamilton; S D Longman; J Norton; R H Poyser
Journal:  J Cardiovasc Pharmacol       Date:  1986 Jul-Aug       Impact factor: 3.105

5.  Evidence that pinacidil may promote the opening of ATP-sensitive K+ channels yet inhibit the opening of Ca2(+)-activated K+ channels in K(+)-contracted canine mesenteric artery.

Authors:  K Masuzawa; T Matsuda; M Asano
Journal:  Br J Pharmacol       Date:  1990-05       Impact factor: 8.739

6.  The action of diazoxide and minoxidil sulphate on rat blood vessels: a comparison with cromakalim.

Authors:  D T Newgreen; K M Bray; A D McHarg; A H Weston; S Duty; B S Brown; P B Kay; G Edwards; J Longmore; J S Southerton
Journal:  Br J Pharmacol       Date:  1990-07       Impact factor: 8.739

7.  Effects of cromakalim, RP49356, diazoxide, glibenclamide and galanin in rat portal vein.

Authors:  J Longmore; D T Newgreen; A H Weston
Journal:  Eur J Pharmacol       Date:  1990-11-06       Impact factor: 4.432

8.  N''-cyano-N-4-pyridyl-N'-1,2,2-trimethylpropylguanidine, monohydrate (P 1134): a new, potent vasodilator.

Authors:  E Arrigoni-Martelli; C K Nielsen; U B Olsen; H J Petersen
Journal:  Experientia       Date:  1980-04-15

9.  The effect of cromakalim on the smooth muscle of the guinea-pig urinary bladder.

Authors:  C D Foster; K Fujii; J Kingdon; A F Brading
Journal:  Br J Pharmacol       Date:  1989-05       Impact factor: 8.739

10.  Attenuation of nocturnal asthma by cromakalim.

Authors:  A J Williams; T H Lee; G M Cochrane; A Hopkirk; T Vyse; F Chiew; E Lavender; D H Richards; S Owen; P Stone
Journal:  Lancet       Date:  1990-08-11       Impact factor: 79.321

View more
  14 in total

Review 1.  Pharmacology of the potassium channel openers.

Authors:  G Edwards; A H Weston
Journal:  Cardiovasc Drugs Ther       Date:  1995-03       Impact factor: 3.727

2.  Pharmacological characterization of the inwardly-rectifying current in the smooth muscle cells of the rat bladder.

Authors:  M E Green; G Edwards; A J Kirkup; M Miller; A H Weston
Journal:  Br J Pharmacol       Date:  1996-12       Impact factor: 8.739

3.  Potassium channel agonists cause penile erection in cats.

Authors:  Wayne J G Hellstrom; Run Wang; Philip J Kadowitz; Floyd R Domer
Journal:  Int J Impot Res       Date:  1992       Impact factor: 2.896

4.  Actions of ZD0947, a novel ATP-sensitive K+ channel opener, on membrane currents in human detrusor myocytes.

Authors:  M Aishima; T Tomoda; T Yunoki; T Nakano; N Seki; Y Yonemitsu; K Sueishi; S Naito; Y Ito; N Teramoto
Journal:  Br J Pharmacol       Date:  2006-10-03       Impact factor: 8.739

Review 5.  Leaky urothelium and/or vesical ischemia enable urinary potassium to cause idiopathic urgency/frequency syndrome and urge incontinence.

Authors:  G Hohlbrugger
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  1996

6.  Comparison of the cromakalim antagonism and bradycardic actions of a series of novel alinidine analogues in the rat.

Authors:  J L Challinor-Rogers; T K Hay; G A McPherson
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-08       Impact factor: 3.000

Review 7.  Signal transduction underlying the control of urinary bladder smooth muscle tone by muscarinic receptors and beta-adrenoceptors.

Authors:  Elfaridah P Frazier; Stephan L M Peters; Alan S Braverman; Michael R Ruggieri; Martin C Michel
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-12-04       Impact factor: 3.000

8.  Effects of pinacidil on arterial and venous resistances and mean circulatory filling pressure in rats.

Authors:  R P Waite; S L Lim; C C Pang
Journal:  Br J Pharmacol       Date:  1995-10       Impact factor: 8.739

Review 9.  Management of overactive bladder syndrome.

Authors:  Sushma Srikrishna; Dudley Robinson; Linda Cardozo; Maria Vella
Journal:  Postgrad Med J       Date:  2007-07       Impact factor: 2.401

10.  Characterization of potassium currents modulated by BRL 38227 in rat portal vein.

Authors:  T Noack; P Deitmer; G Edwards; A H Weston
Journal:  Br J Pharmacol       Date:  1992-07       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.